Table 3.
Multivariate analyses of predicting hematoma expansion in the original cohort.
| Crude OR (95%CI) | P-value | Adjusteda OR (95%CI) | P-value | |
|---|---|---|---|---|
| >6 mL growth (N = 200) | ||||
| WBC count | 0.96 (0.92–1.01) | 0.088 | 0.94 (0.90–0.99) | 0.021 |
| Neutrophil count | 0.94 (0.90–0.99) | 0.008 | 0.93 (0.89–0.98) | 0.008 |
| Monocyte count | 1.74 (1.10–2.78) | 0.019 | 1.45 (0.89–2.35) | 0.131 |
| Lymphocyte count | 1.27 (1.09–1.49) | 0.003 | 1.09 (0.90–1.31) | 0.385 |
| Eosinophil count | 7.11 (2.30–21.97) | 0.001 | 3.64 (1.04–12.7) | 0.043 |
| >12.5 mL growth (N = 116) | ||||
| WBC count | 0.97 (0.92–1.02) | 0.234 | 0.98 (0.92–1.04) | 0.495 |
| Neutrophil count | 0.94 (0.89–0.99) | 0.023 | 0.96 (0.91–1.02) | 0.229 |
| Monocyte count | 2.09 (1.26–3.48) | 0.004 | 1.98 (1.19–3.30) | 0.009 |
| Lymphocyte count | 1.35 (1.13–1.61) | 0.001 | 1.14 (0.92–1.40) | 0.233 |
| Eosinophil count | 11.39 (3.27–39.66) | <0.001 | 5.03 (1.13–22.3) | 0.034 |
| >33% growth (N = 174) | ||||
| WBC count | 0.92 (0.88–0.97) | 0.001 | 0.94 (0.89–0.99) | 0.02 |
| Neutrophil count | 0.89 (0.85–0.94) | <0.001 | 0.96 (0.87–0.97) | 0.003 |
| Monocyte count | 1.79 (1.12–2.88) | 0.016 | 1.62 (0.99–2.64) | 0.056 |
| Lymphocyte count | 1.42 (1.21–1.67) | <0.001 | 1.18 (0.99–1.42) | 0.072 |
| Eosinophil count | 19.12 (5.81–62.94) | <0.001 | 6.71 (1.73–25.9) | 0.006 |
| >6 mL or 33% growth (N = 225) | ||||
| WBC count | 0.95 (0.91–0.99) | 0.008 | 0.93 (0.89–0.98) | 0.004 |
| Neutrophil count | 0.92 (0.88–0.96) | <0.001 | 0.92 (0.87–0.96) | <0.001 |
| Monocyte count | 1.73 (1.09–2.75) | 0.019 | 1.44 (0.90–2.30) | 0.127 |
| Lymphocyte count | 1.37 (1.17–1.59) | <0.001 | 1.19 (0.99–1.42) | 0.053 |
| Eosinophil count | 10.38 (3.37–32.02) | <0.001 | 4.66 (1.28–17.02) | 0.02 |
| >12.5 mL or 33% growth (N = 182) | ||||
| WBC count | 0.93 (0.89–0.98) | 0.004 | 0.95 (0.90–0.99) | 0.034 |
| Neutrophil count | 0.90 (0.86–0.95) | <0.001 | 0.93 (0.88–0.98) | 0.005 |
| Monocyte count | 1.80 (1.12–2.89) | 0.015 | 1.61 (0.92–2.61) | 0.124 |
| Lymphocyte count | 1.41 (1.20–1.66) | <0.001 | 1.20 (0.92–1.43) | 0.112 |
| Eosinophil count | 17.07 (5.25–55.49) | <0.001 | 6.51 (1.71–24.82) | 0.006 |
OR for 103 cells increase. N represents the number of positive hematoma expansion.
a
Adjusted by sex, hypertension, history of cerebral hemorrhage, glasgow coma scale score, time from symptom onset to initial CT, and baseline hematoma volume. WBC, white blood cell; OR, odds ratio; CI, confidence interval; CT, computed tomography.